Skip to main content

Payments and invoicing on AICIS Business Services are not available from 5pm Friday 1 July to 6am Saturday 2 July (AEDT). We apologise for the inconvenience.

Rolling Action Plan – our chemical evaluations list

The Rolling Action Plan lists our current and recently completed chemical evaluations. The Rolling Action Plan forms part of our approach to protecting human health and the environment.

Decorative image

What is the Rolling Action Plan?

The Rolling Action Plan is our work plan for prioritising chemicals for evaluation, which are selected based on the outcomes of our Evaluation Selection Analysis (ESA) process.

The plan lists our proposed, ongoing and recently completed chemical evaluations. It doesn't include evaluations initiated for chemicals under a current assessment certificate. 

Our Evaluations Roadmap describes our strategic approach to protect human health and the environment by providing information and recommendations about managing the risks that arise from introducing and using industrial chemicals. By prioritising chemicals on the Inventory, our evaluations are more risk-proportionate, timely and targeted.

For each entry, the Rolling Action Plan includes the: 

  • subject of the evaluation – typically the chemical name or chemical group name
  • reason for the evaluation
  • time it takes to do the evaluation
  • focus of the evaluation – chemical identity, and human health or the environment (or both)
  • current status of the evaluation – for example, in progress, public consultation, completed
  • amendments to our list of evaluation candidates.

The publication of the subject, reason and time period within which the evaluation will be conducted satisfies the requirements of the Industrial Chemicals Act 2019  for initiating an evaluation. 

During an Evaluation Selection Analysis (ESA) process we will identify chemicals that may pose a risk to human health and/or the environment. We will also identify chemicals that are unlikely to require further regulation to manage risks based on their human health and environmental hazards and exposures. This will allow us to publish Evaluation Statements for these chemicals and provide the rationale for not undertaking more detailed evaluations.

When do we update the Rolling Action Plan? 

Generally, we will update the Rolling Action Plan after publishing our evaluations. We publish a notice on our website when we update it. 

We will add details of newly initiated evaluations. Other changes to the rolling action plan may include amendments to the: 

  • evaluation subject
  • time it takes to do the evaluation
  • reason for the evaluation

We may need to update the Rolling Action Plan at other times. If we do, we’ll consult with interested parties and publish a notice on our website. These updates can happen for many reasons, including:

  • an adverse event that warrants a chemical evaluation
  • a stakeholder request to evaluate a chemical has been prioritised through ESA process
  • a post-assessment obligation leads to an evaluation
  • we are informed that new information will become available for the chemical that warrants a chemical evaluation

The identified chemicals covered by the subject of the evaluation may change as the evaluation progresses due to new information becoming available.

Completed evaluations remain on the Rolling Action Plan until the next set of evaluations are published. 

Note: Please contact us if you have any information about any chemical listed on the Rolling Action Plan.

Rolling Action Plan

We publish and maintain 2 lists as part of the Rolling Action Plan. 

  1. List of evaluations that are in progress, currently open for public consultation or recently completed. Each evaluation could be for a single chemical or a group of chemicals.
  2. Downloadable spreadsheet of chemicals that are covered by an evaluation that is in progress, currently open for public consultation, or recently completed. These chemicals can change during the course of the evaluation if new information becomes available.

Recently completed evaluations

ID Subject of evaluation Reason for evaluation Time period for evaluation Focus Status
EVA00003 1,4-Dioxane New information has become available about risks to human health 30/06/2022 Health Completed
EVA00006 delta-Damascones The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00007 2-Propenamide, N,N-dimethyl- (dimethylacrylamide) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00008 Straight run gas oils An evaluation is required to provide information on the risks to human health 30/06/2022 Health Completed
EVA00017 Exaltone and related macrocyclic musks The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00021 1,3,5-Triazine-2,4,6-triamine (melamine) New information is available about human health and environmental risks. 30/06/2022 Health and environment Completed
EVA00025 Phenyl propanaldehydes The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00026 Lead and lead manufacturing byproducts The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00031 Trimellitates (high molecular weight) An evaluation is needed to provide information on human health risks. 30/06/2022 Health Completed
EVA00032 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl- (theophylline) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00036 Acetic acid, (4-nonylphenoxy)- The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00038 Ethylene brassylate and zenolide The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00048 1,6-Octadiene, 7-methyl-3-methylene-(Myrcene) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00049 1-Propene, 2,3,3,3-tetrafluoro- Information has been provided as a result of the specific information obligations on the terms of the inventory listing 30/06/2022 Health Completed
EVA00050 2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-[(4-sulfo-1-naphthalenyl)azo]-, compounds The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00051 2-Propenoic acid, 2-methoxyethyl ester (2-methoxyethyl acrylate) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00053 Phenol, 4,4'-sulfonylbis- (BPS) The Evaluation Selection Analysis indicated a potential risk to environment 30/06/2022 Environment Completed
EVA00054 Long-chain alkyl hydroxyethyl imidazolines Evaluation Selection Analysis indicated a potential human health risk. 30/06/2022 Health Completed
EVA00062 Glycidyl acrylate and glycidyl methacrylate The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00067 Octynoic and nonynoic acid esters The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00071 Benzalkonium halides An evaluation is required to provide information on the risks to human health 30/06/2022 Health Completed
EVA00073 Siloxanes substituted with 2-methoxyethanol The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00074 Dodecylphenols The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00075 2,5,8,11,14-Pentaoxapentadecane (tetraglyme) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00076 Compounds of dimethyltin The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00077 Compounds of dioctyltin The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00078 Compounds of dibutyltin The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00079 Benzene, 1-chloro-2-nitro- (2-chloronitrobenzene) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00080 1-Propanol, 2,2-dimethyl-, tribromo derivative The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00081 Benzene, 2,4-dichloro-1-nitro- (2,4-dichloronitrobenzene) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00082 Benzene, 1,4-dichloro-2-nitro- (2,5-dichloronitrobenzene) The Evaluation Selection Analysis indicated a potential risk to human health 30/06/2022 Health Completed
EVA00083 Ethanone, 1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl)-, [3R-(3.alpha.,3a.beta.,7.beta.,8a.alpha.)]- (acetyl cedrene) Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2022 Environment Completed
EVA00084 4-tert-butylphenol and 4-tert-pentylphenol Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2022 Environment Completed
EVA00085 2-phenylphenol and salts Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2022 Environment Completed
EVA00086 Chemicals that are unlikely to require further regulation to manage risks to environment Evaluation is needed to provide information on environmental risks. 30/06/2022 Environment Completed
EVA00087 Chemicals not considered for in depth evaluation – Not commercially active in Australia Evaluation is needed to provide information on human health and environmental risks. 30/06/2022 Health and environment Completed
EVA00088 Chemicals that are unlikely to require further regulation to manage risks to human health Evaluation is needed to provide information on human health risks. 30/06/2022 Health Completed
EVA00089 2,5-Furandione, telomer with ethenylbenzene and (1-methylethyl)benzene, hydrolyzed, 3-(dimethylamino)propyl imide, imide with polyethylene-polypropylene glycol 2-aminopropyl Me ether, 2-[(C10-16-alkyloxy)methyl]oxirane-quaternized, benzoates (salts) New information is available about the chemical's identity. 30/06/2022 Chemical identity Completed

 

Evaluations in progress or under public consultation

Download

EvA ID Subject of evaluation Reason for evaluation Time period for evaluation Focus Status Amendments to RAP
EVA00022 Octanamide, N-Hydroxy- To evaluate information submitted by industry to meet their obligation in the terms of the Inventory listing. 31/12/2022 Health In Progress The timeframe for completion of evaluation has been extended to enable provision of information to inform our risk assessment.
EVA00040 Musk tibetene and a structural analogue Evaluation Selection Analysis indicated a potential environmental risk. 31/12/2022 Environment In Progress The timeframe for completion of evaluation has been extended to enable provision of information to inform our risk assessment.
EVA00041 1,4:7,10-Dimethanodibenzo[a,e]cyclooctene, 1,2,3,4,7,8,9,10,13,13,14,14-dodecachloro-1,4,4a,5,6,6a,7,10,10a,11,12,12a-dodecahydro- (Dechlorane Plus) Evaluation Selection Analysis indicated a potential human health and environmental risk. 30/06/2023 Health and Environment In Progress

The timeframe for completion of this evaluation has been extended to enable consideration of the outcome from a critical long term aquatic toxicity study. The study is expected to be released to coincide with the international meeting that informs decisions under the Stockholm Convention

EVA00055 Benzene, 1,2,3,4,5-pentachloro- (PeCB) Evaluation is needed to provide information on human health and environmental risks. 31/12/2022 Health and Environment In Progress The timeframe for completion of evaluation has been extended to enable provision of information to inform our risk assessment.
EVA00056 Benzene, hexachloro- (HCB) Evaluation is needed to provide information on human health and environmental risks. 31/12/2022 Health and Environment In Progress The timeframe for completion of evaluation has been extended to enable provision of information to inform our risk assessment.
EVA00060 Carbamic acid, 1H-benzimidazol-2-yl-, methyl ester (carbendazim) An evaluation or assessment recommended further evaluation of specific issues related to the chemical(s). 31/12/2022 Health and Environment In Progress The timeframe for completion of evaluation has been extended to enable evaluation of new information when it becomes available.
EVA00090 1-bromo-3-chloropropane and 1,3-dibromopropane Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00091 1-methoxy-4-(2-propenyl)benzene (estragole) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00092 2-Propenamide, 2-methyl- (methacrylamide) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00093 Chemicals not considered for in depth evaluation – Not commercially active in Australia Evaluation is needed to provide information on human health and environmental risks. 30/06/2023 Health and Environment In Progress -
EVA00094 Chemicals that are unlikely to require further regulation to manage risks to environment Evaluation is needed to provide information on environmental risks. 30/06/2023 Environment In Progress -
EVA00095 Chemicals that are unlikely to require further regulation to manage risks to human health Evaluation is needed to provide information on human health risks. 30/06/2023 Health In Progress -
EVA00096 Benzaldehyde Evaluation is needed to provide information on human health risks. 30/06/2023 Health In Progress -
EVA00097 Salts of aniline Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00098 Benzene, 1-chloro-4-(trifluoromethyl)- Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00099 Peroxide, bis(1-methyl-1-phenylethyl) (dicumyl peroxide) Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00100 Use of aluminium in antiperspirants Evaluation is needed to provide information on human health risks. 30/06/2023 Health In Progress -
EVA00101 Polymers incorporating glycidyl methacrylate Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00102 Water soluble arsenic compounds Evaluation is needed to provide information on environmental risks. 30/06/2023 Environment In Progress -
EVA00103 Tocopherols and their salts and esters Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00104 Cresyl phosphates and xylyl phosphates Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment In Progress -
EVA00105 Water-soluble zinc salts Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment In Progress -
EVA00106 Hydroquinone and p-benzoquinone Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment In Progress -
EVA00107 Cadmium sulfide pigments Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment In Progress -
EVA00108 Triphenyl phosphate and diphenyl phosphate Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment In Progress -
EVA00109 Phenylenediamines Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment In Progress -
EVA00110 Glyoxylic acid Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00111 Cyclohexanamine, 4,4'-methylenebis[2-methyl- Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00112 Carbamic acid, butyl-, 3-iodo-2-propynyl ester (IPBC) Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment In Progress -
EVA00113 Propyl and butyl phenols Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00114 Long chain (C greater than or equal to 10) alkyl benzene sulfonates Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00115 Polymers with pendant acrylates Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
EVA00116 Lauryl (dodecyl) sulfates Evaluation Selection Analysis indicated a potential environmental risk. 30/06/2023 Environment In Progress -
EVA00117 Alkyl diphenyl oxide sulfonates Evaluation Selection Analysis indicated a potential human health risk. 30/06/2023 Health In Progress -
Last updated
Was this page helpful?
For broken links or technical issues, please provide as much detail as possible. Do not include your name, email address and other personal or commercially sensitive information.

Keep informed with updates